Entera Bio's total assets for Q2 2026 were $19.48M, an increase of 48.37% from the previous quarter. DE:5DT total liabilities were $12.21M for the fiscal quarter, a 400.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.